Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| MK0663-081 | |||
| 2005_062 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MK0663; etoricoxib / Duration of Treatment: 5 Days | Drug | |||
| Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Patient assessment of pain (0- to 4- Likert scale) |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Global Assessment of Response to Therapy (0- to 4- point scale) | ||
| Investigator Global Assessment of Response to Therapy (0- to 4- point scale) | ||
| Tenderness of the study joint (0- to 3-point scale) |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Monitor | Merck Sharp & Dohme LLC | Study Director |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17588299 | Derived | Navarra S, Rubin BR, Yu Q, Smugar SS, Tershakovec AM. Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout. Curr Med Res Opin. 2007 Jul;23(7):1685-91. doi: 10.1185/030079907x210750. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Swelling of the study joint (0- to 3-point scale) |
| ID | Term |
|---|---|
| D000077613 | Etoricoxib |
| D000081206 | Duration of Therapy |
| ID | Term |
|---|---|
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D009930 | Organic Chemicals |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided